Early data from the PEACE-1 trial

The so-called PEACE-1 trial is an ongoing Phase III trial among men diagnosed with de novo metastatic castration-sensitive prostate cancer (mCSPC). … READ MORE …

Just how often do biopsy and blood samples get mixed up?

We know it happens. You are told your PSA has risen unexpectedly … but when you get it retested, it hasn’t. Worse still … you are told you have cancer when you don’t! … READ MORE …

Results of the PCaI prostate cancer patient “value” survey

Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …

Did unequal use of ADT in treatment affect mortality rates in the ERSPC and Göteborg trials?

A new article by Australian researchers in the Journal of the National Cancer Institute has suggested that the more widespread use of androgen deprivation therapy (ADT) among unscreened patients (controls) in the ERSPC and the Göteborg studies may have substantially affected patient mortality data in these trials. … READ MORE …